To further assess the potency of MI-2 against MCL in vivo, we engineered JeKo BTK KD-2 cells to stably express the luciferase reporter gene and then established JeKo BTK KD-2 CDX models. The gene discussed is BTK; the disease is mantle cell lymphoma.